Skip Navigation

Correction for J. Natl. Cancer Inst. 100 (2) 156.
Correction for Scappaticci et al., J. Natl. Cancer Inst. 99 (16) 1232-1239.

Journal of the National Cancer Institute Advance Access originally published online on April 29, 2008
JNCI Journal of the National Cancer Institute 2008 100(9):685; doi:10.1093/jnci/djn126
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/9/685    most recent
djn126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2008.

CORRESPONDENCE

Erratum

Erratum: Arterial Thromboembolic Events and Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab, F.A. Scappaticci, J.R. Skillings, S.N. Holden, H.-P. Gerber, K. Miller, F. Kabbinavar, E. Bergsland, J. Ngai, E. Holmgren, J. Wang, H. Hurwitz [ J Natl Cancer Inst 2007;99:1232-1239 (Issue 16) and its erratum J Natl Cancer Inst 2008;100:156 (Issue 2)]. The sentences in lines 3–7, left column, on page 1235 of the article, and lines 15–23 of the erratum should read as follows: The cytotoxic agents administered varied with tumor type; however, 1647 (94%) of the 1745 patients received a fluoropyrimidine-based therapy (5-fluorouracil or capecitabine). In addition, 668 (69%) of the bevacizumab-treated patients received it at a dose intensity of 2.5 mg/kg per week, and 295 (31%) received it at 5 mg/kg per week. The last complete sentence on page 1236 should read as follows: In particular, 60 (27.3%) of the 220 aspirin users had a history of arterial thromboembolic events, compared with 86 (5.6%) of the 1525 aspirin nonusers. The authors and the journal regret these errors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/9/685    most recent
djn126v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?